Mayo Clinic’s Vyant Bio, Inc. Common Stock VYNT Stock Holding History

Mayo Clinic’s Portfolio VYNT Stock Details VYNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-27,742	Closed	-$16.1K	–	13
2023 Q1	$16.1K	Hold	27,742	–	–	0.01%	13
2022 Q4	$19.4K	Buy	+27,742	New	+$45.1K	0.01%	12
2020 Q4	–	Sell	-89	Closed	-$184K	–	10
2020 Q3	$184K	Hold	89	–	–	0.25%	9
2020 Q2	$1K	Hold	89	–	–	﹤0.01%	9
2020 Q1	$1K	Hold	89	–	–	﹤0.01%	8
2019 Q4	$3K	Buy	+89	New	+$2.13K	﹤0.01%	8

Other funds holding VYNT

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Mayo Clinic's VYNT Position: Q2 2023 in Review

Mayo Clinic sold out of Vyant Bio, Inc. Common Stock (VYNT) in Q2 2023, closing a stake of 27,742 shares — an estimated $16.1K sold.

Mayo Clinic first reported a position in VYNT in Q4 2019 and held it in 6 quarters. The position peaked at $184K in Q3 2020. 1 fund tracked by Wall St. Rank holds VYNT as of Q2 2023.

Mayo Clinic reported no remaining Vyant Bio, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Mayo Clinic sold 27,742 Vyant Bio, Inc. Common Stock shares in Q2 2023, an estimated $16.1K.
Mayo Clinic first reported a position in Vyant Bio, Inc. Common Stock in Q4 2019 and held it in 6 quarters.
Mayo Clinic's Vyant Bio, Inc. Common Stock position peaked at $184K in Q3 2020.
1 fund tracked by Wall St. Rank held Vyant Bio, Inc. Common Stock as of Q2 2023.

Based on Mayo Clinic's 13F filing for Q2 2023, filed 9 Aug 2023.